Current Protein Identity:F6V9L3 New Search
Main Difference Dimensions in This Set
Different construct Different assembly state Different ligand/ion Different experimental conditions Different structure-quality metrics

Difference tags compare only the current result set; every original PDB and assembly record remains separate.

Related-Structure Differences

Each row represents one biological assembly in one PDB entry; multiple monomers of the same protein are listed separately.

PDB Entry Assembly / Oligomeric State Construct Mutations and Modifications Ligands, Ions and Non-polymers Experimental Method Experimental Conditions Structure Quality
7FC3 structure of NL63 receptor-binding domain complexed with horse ACE2 Deposited 2021-07-13 Assembly 1 Other combination Heteromer;Protein × 2 PDB declaration: dimeric(2) Consistent with protein count
Chain A 19–613(595 aa)
Not recorded NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 1 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, SITTING DROP;289.15 K;1.8M Ammonium sulfate, 0.1M BIS-TRIS pH6.5, 2% v/v polyethylene glycol monomethylether 550
Resolution 3.19 Å R-free 0.283
7FC5 Crystal structure of SARS-CoV-2 RBD and horse ACE2 Deposited 2021-07-13 Assembly 1 Protein heterocomplex Heteromer;Protein × 2 PDB declaration: dimeric(2) Consistent with protein count
Chain A 19–615(597 aa)
Not recorded NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 5 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, SITTING DROP;291.15 K;0.2M Sodium formate, 20% w/v polyethylene glycol 3350
Resolution 2.89 Å R-free 0.259
7FC6 Crystal structure of SARS-CoV RBD and horse ACE2 Deposited 2021-07-13 Assembly 1 Other combination Heteromer;Protein × 2 PDB declaration: dimeric(2) Consistent with protein count
Chain A 19–615(597 aa)
Not recorded NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 2 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, SITTING DROP;291.15 K;0.03M Citric acid/0.07M BIS-TRIS propane pH7.6, 20% w/v polyethylene glycol 3350
Resolution 2.65 Å R-free 0.235
7W6R Structure of Bat coronavirus RaTG13 spike receptor-binding domain complexed with its receptor equine ACE2 Deposited 2021-12-02 Assembly 1 Protein heterocomplex Heteromer;Protein × 2 PDB declaration: dimeric(2) Consistent with protein count
Chain A 19–614(596 aa)
Not recorded ZN ZINC ION × 1 NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 1 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, SITTING DROP;291 K;0.2M Lithium chloride, 0.1M Tris 8.0, 20% (w/v) PEG 6000
Resolution 2.60 Å R-free 0.194
7W6U Structure of SARS-CoV-2 spike receptor-binding domain complexed with its receptor equine ACE2 Deposited 2021-12-02 Assembly 1 Protein heterocomplex Heteromer;Protein × 2 PDB declaration: dimeric(2) Consistent with protein count
Chain A 19–614(596 aa)
Not recorded ZN ZINC ION × 1 NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 1 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, SITTING DROP;277 K;10% (w/v) PEG 1000, 10% (w/v) PEG 8000
Resolution 2.56 Å R-free 0.227
7XBY The crystal structure of SARS-CoV-2 Omicron BA.1 variant RBD in complex with equine ACE2 Deposited 2022-03-22 Assembly 1 Protein heterocomplex Heteromer;Protein × 2 PDB declaration: dimeric(2) Consistent with protein count
Chain A 1–805(805 aa)
Not recorded ZN ZINC ION × 1 BR BROMIDE ION × 6 NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 1 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, SITTING DROP;291 K;0.2M Sodium bromide, 0.1M Bis-Tris propane 8.5, 20 % (w/v) PEG 3350
Resolution 2.85 Å R-free 0.263